Contemporary antimicrobial activity of triple antibiotic ointment: A multiphased study of recent clinical isolates in the United States and Australia

Diagnostic Microbiology and Infectious Disease

Volumn 54, Issue 1, 2006, Pages 63-71

  Jones, Ronald N ^a   Li, Qing ^b   Kohut, Bruce ^b   Biedenbach, Douglas J ^a   Bell, Jan ^c   Turnidge, John D ^c  

^a JMI LABORATORIES   (United States)

^b PFIZER INC   (United States)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Australia; Mupirocin; Resistance; Staphylococcus aureus; Triple antibiotic ointment; USA

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BACITRACIN; GENTAMICIN; NEOMYCIN; POLYMYXIN B; PSEUDOMONIC ACID; STREPTOMYCIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; AUSTRALIA; BACTERIAL INFECTION; BACTERIAL STRAIN; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CROSS RESISTANCE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; MICROBIAL ACTIVITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; UNITED STATES;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; AUSTRALIA; BACITRACIN; BACTERIA; BACTERIAL INFECTIONS; DRUG COMBINATIONS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; NEOMYCIN; OINTMENTS; POLYMYXIN B; POPULATION SURVEILLANCE; UNITED STATES;

EID: 29144480960     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2005.08.009     Document Type: Article

References (45)

1. P.D. Arkwright, T.O. Daniel, D. Sanyal, T.J. David, and L. Patel Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-specialty center Arch. Dermatol. 138 2002 939 941
2. A.L. Barry The antimicrobic susceptibility test: principles and practices 1976 Lea & Febiger Philadelphia
3. R.S. Berger, A.S. Pappert, P.S. Van Zile, and W.E. Cetnarowski A newly formulated topical triple-antibiotic ointment minimizes scarring Cutis 65 2000 401 404
4. J.S. Bertino Jr. Intranasal mupirocin for outbreaks of methicillin-resistant Staphylococcus aureus Am. J. Health Syst. Pharm. 54 1997 2185 2191
5. F. Chaves, J. Garcia-Martinez, S. de Miguel, and J.R. Otero Molecular characterization of resistance to mupirocin in methicillin-susceptible and -resistant isolates of Staphylococcus aureus from nasal samples Clin. Microbiol. 42 2004 822 824
6. W. Cetnarowski, and S. Gabriel Comparison of two neosporin ointment formulations on the time to healing of human dermabrasion wounds Clin. Pharmacol. Ther. 63 1998 213
7. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing Document M100-S15 2005 CLSI Wayne, PA
8. J.M. Conly, and B.L. Johnston Mupirocin-are in danger of loosing it? Can. J. Infect. Dis. 13 2002 1 5
9. B.D. Cookson The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice J. Antimicrob. Chemother. 41 1998 11 18
10. G. Coombs, M. Malkowski, J. Pearson, and Community MRSA in Australia 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, September 27-30, San Diego, CA 2002
11. L.M. Desphande, A.M. Fix, M.A. Pfaller, R.N. Jones for the SENTRY Antimicrobial Surveillance Program Participants Group Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods Diagn. Microbiol. Infect. Dis. 42 2002 283 290
12. D.J. Dire, M. Coppola, D.A. Dwyer, J.J. Lorette, and J.L. Karr Prospective evaluation of topical antibiotics for preventing infections in uncomplicated soft-tissue wounds repaired in the ED Acad. Emerg. Med. 2 1995 4 10
13. P.C. Fuchs, R.N. Jones, and A.L. Barry Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic J. Clin. Microbiol. 28 1990 608 609
14. A.T. Fuller, G. Mellows, and M. Woolford Pseudomonic acid: an antibiotic produced by Pseudomonas fluorescens Nature 234 1971 416 417
15. S. Fung, S. O'Grady, C. Kennedy, H. Dedier, I. Campbell, and J. Conly The utility of polysporin ointment in the eradication of methicillin-resistant Staphylococcus aureus colonization: a pilot study Infect. Control. Hosp. Epidemiol. 21 2000 653 655
16. A.C. Gales, S.S. Andrade, H.S. Sader, and R.N. Jones Activity of mupirocin and 14 additional antibiotics against staphylococci isolated from Latin American hospitals: report from the SENTRY Antimicrobial Surveillance Program J. Chemother. 16 2004 323 328
17. A.C. Gales, A.O. Reis, and R.N. Jones Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines J. Clin. Microbiol. 39 2001 183 190
18. A. Giacometti, O. Cirioni, A.M. Schimizzi, M.S. Del Prete, F. Barchiesi, M.M. D'Errico, E. Petrelli, and G. Scalise Epidemiology and microbiology of surgical wound infections J. Clin. Microbiol. 38 2000 918 922
19. GlaxoSmithKline Bactroban nasal package insert 2001 GSK Research Triangle Park, NC http://www.gsk.com/products/bactronban.us.htm.
20. J.O. Hendley, and K.M. Ashe Effect of topical antimicrobial treatment on aerobic bacteria in the stratum corneum of human skin Antimicrob. Agents Chemother. 35 1991 627 631
21. J.O. Hendley, and K.M. Ashe Eradication of resident bacteria of normal human skin by antimicrobial ointment Antimicrob. Agents Chemother. 47 2003 1988 1990
22. R.N. Jones, J. Milazzo, and M. Seidlin Ofloxacin otic solution for therapy of otitis externa in children and adults Arch. Otolaryngol. Head Neck Surg. 123 1997 1193 1200
23. J.T. Kirby, A.H. Mutnick, R.N. Jones, D.J. Biedenbach, M.A. Pfaller for the SENTRY Participants Group Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000) Diagn. Microbiol. Infect Dis. 43 2002 303 309
24. M. Kresken, D. Hafner, F.-J. Schmitz, T.A. Wichelhaus on behalf of the Working Group for Antimicrobial Resistance of the Paul-Ehrlich-Society for Chemotherapy Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001 Int. J. Antimicrob. Agents 23 2004 577 581
25. J.J. Leyden, and A.M. Kligman Contact dermatitis to neomycin sulfate JAMA 242 1979 1276 1278
26. T.A. Leski, M. Gniadkowski, A. Skoczynska, E. Stefaniuk, K. Trzcinski, and W. Hryniewicz Outbreak of mupirocin-resistant staphylococci in a hospital in Warsaw, Poland, due to plasmid transmission and clonal spread of several strains J. Clin. Microbiol. 37 1999 2781 2788
27. Members of the SFM Antibiogram Committee Comite de l'Antibiogramme de la Societe Francaise de Microbiologie. Report 2003 Int. J. Antimicrob. Agents 21 2003 364 391
28. Multiple authors Update on topical antibiotic therapy: changing antibiotic susceptibility patterns and clinical applications Cutis 71 2003 1 24
29. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically Approved standard 6th ed. 2003 NCCLS Wayne, PA (Document M7-A6)
30. M. Pezzati, E.C. Biagioli, E. Martelli, B. Gambi, R. Biagiotti, and F.F. Rubaltelli Umbilical cord care: the effect of eight different cord-care regiments on cord separation time and other outcomes Biol. Neonate 81 2002 38 44
31. J.A. Poupard Update on mupirocin resistance J. Chemother. 7 Suppl 3 1995 71 74
32. S.D. Prystowsky, A.M. Allen, R.W. Smith, J.H. Nonomura, R.B. Odom, and W.A. Akers Allergic contact hypersensitivity to nickel, neomycin, ethylenediamine, and benzocaine: relationships between age, sex, history of exposure, and reactivity to standard patch tests and use tests in a general population Arch. Dermatol. 115 1979 959 962
33. S.D. Prystowsky, J.H. Nonomura, R.W. Smith, and A.M. Allen Allergic hypersensitivity to neomycin: relationship between patch test reactions and "use" tests Arch. Dermatol. 115 1979 713 715
34. R. Sander Otitis externa: a practical guide to treatment and prevention Am. Fam. Physician 63 2001 927 936
35. K.R.N. Santos, L.S. Fonseca, and P.P. Gontijo Filho Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals Infect. Control Hosp. Epidemiol. 17 1996 813 816
36. F.J. Schmitz, E. Lindenlauf, B. Hofmann, A.D. Fluit, J. Verhoef, H.P. Heinz, and M.E. Jones The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals J. Antimicrob. Chemother. 42 1998 489 495
37. B. Slocombe, and C. Perry The antimicrobial activity of mupirocin-an update on resistance J. Hosp. Infect. 19 Suppl B 1991 19 25
38. E. Tacconelli, Y. Carmeli, A. Aizer, G. Ferreira, M.G. Foreman, and E.MC. D'Agata Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis Clin. Infect. Dis. 37 2003 1629 1638
39. M.S. Terpenning, S.F. Bradley, J.Y. Wan, C.E. Chenoweth, K.A. Jorgensen, and C.A. Kauffman Colonization and infection with antibiotic-resistant bacteria in a long-term care facility J. Am. Geriatr. Soc. 42 1994 1062 1069
40. A. Upton, S. Lang, and H. Heffernan Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance J. Antimicrob. Chemother. 51 2003 613 617
41. B.A. Waisbren Neomycin Practitioner 176 1956 39 46
42. B.A. Waisbren The sensitivity of staphylococci to antibiotics. A five-year study of sensitivity, usage and cross resistance in a general hospital Arch. Intern. Med. 101 1958 397 406
43. E.S. Walker, F. Levy, M. Shorman, G. David, J. Abdalla, and F.A. Sarubbi A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions J. Clin. Microbiol. 42 2004 2792 2795
44. H. Watanabe, H. Masaki, N. Asoh, K. Watanabe, K. Oishi, S. Kobayashi, A. Sato, R. Sugita, and T. Nagatake Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus J. Clin. Microbiol. 39 2001 3775 3777
45. H.-J. Yun, S.W. Lee, G.M. Yoon, S.Y. Kim, S. Choi, Y.S. Lee, E.-C. Coi, and S. Kim Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital J. Antimicrob. Chemother. 51 2003 619 623